Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weger

Showing results (931-940 of 1,018) with videos related to

Pageof 102
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 15, 2017
A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavirVincent A de Weger, Frederik E Stuurman, Jeroen J M A Hendrikx, et al.
Heart Rhythm|April 3, 2017
Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathiesShahrzad Sepehrkhouy, Johannes M I H Gho, René van Es, et al.
European Journal of Heart Failure|July 31, 2012
Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device supportSjoukje I Lok, Bjorn Winkens, Roel Goldschmeding, et al.
Psoriasis (Auckland, N.Z.)|July 3, 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive StudyUlrich Mrowietz, Rachel Sommer, Sascha Gerdes, et al.
Psoriasis (Auckland, N.Z.)|May 18, 2026
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE StudyUlrich Mrowietz, Rachel Sommer, Ziad Reguiai, et al.
American Journal of Clinical Pathology|March 18, 2015
Comparison of next-generation sequencing and mutation-specific platforms in clinical practiceJohn W J Hinrichs, W T Marja van Blokland, Michiel J Moons, et al.
Clinical Pharmacology in Drug Development|October 6, 2020
A Phase 1 Dose-Escalation Study of Low-Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid TumorsVincent A de Weger, Marit A C Vermunt, Frederik E Stuurman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
Lipidomics reveals diurnal lipid oscillations in human skeletal muscle persisting in cellular myotubes cultured in vitroUrsula Loizides-Mangold, Laurent Perrin, Bart Vandereycken, et al.
Circulation. Heart Failure|May 4, 2013
Post-transcriptional regulation of α-1-antichymotrypsin by microRNA-137 in chronic heart failure and mechanical supportSjoukje I Lok, Alain van Mil, Niels Bovenschen, et al.
Nature Aging|April 28, 2023
Long-term life history predicts current gut microbiome in a population-based cohort studyJiyeon Si, Jorge F Vázquez-Castellanos, Ann C Gregory, et al.
Pageof 102

Showing results (931-940 of 1,018) with videos related to

Sort By:
Pageof 102
European Journal of Cancer (Oxford, England : 1990)|October 15, 2017
A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavirVincent A de Weger, Frederik E Stuurman, Jeroen J M A Hendrikx, et al.
Heart Rhythm|April 3, 2017
Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathiesShahrzad Sepehrkhouy, Johannes M I H Gho, René van Es, et al.
European Journal of Heart Failure|July 31, 2012
Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device supportSjoukje I Lok, Bjorn Winkens, Roel Goldschmeding, et al.
Psoriasis (Auckland, N.Z.)|July 3, 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive StudyUlrich Mrowietz, Rachel Sommer, Sascha Gerdes, et al.
Psoriasis (Auckland, N.Z.)|May 18, 2026
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE StudyUlrich Mrowietz, Rachel Sommer, Ziad Reguiai, et al.
American Journal of Clinical Pathology|March 18, 2015
Comparison of next-generation sequencing and mutation-specific platforms in clinical practiceJohn W J Hinrichs, W T Marja van Blokland, Michiel J Moons, et al.
Clinical Pharmacology in Drug Development|October 6, 2020
A Phase 1 Dose-Escalation Study of Low-Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid TumorsVincent A de Weger, Marit A C Vermunt, Frederik E Stuurman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
Lipidomics reveals diurnal lipid oscillations in human skeletal muscle persisting in cellular myotubes cultured in vitroUrsula Loizides-Mangold, Laurent Perrin, Bart Vandereycken, et al.
Circulation. Heart Failure|May 4, 2013
Post-transcriptional regulation of α-1-antichymotrypsin by microRNA-137 in chronic heart failure and mechanical supportSjoukje I Lok, Alain van Mil, Niels Bovenschen, et al.
Nature Aging|April 28, 2023
Long-term life history predicts current gut microbiome in a population-based cohort studyJiyeon Si, Jorge F Vázquez-Castellanos, Ann C Gregory, et al.
Pageof 102